Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms for Dyspnea on Exertion in Obese Asthmatic Children
NCT04184609Phase 4Withdrawn
- Sponsor
- The Ohio State University
- Start
- Jul 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salbutamol in asthma, sponsored by The Ohio State University. Planned start Jul 2023; status: withdrawn.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04184609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04184609.